RAA RATIONAL Aktiengesellschaft
RATIONAL Aktiengesellschaft engages in the development, production, and sale of cooking systems for industrial kitchens in Germany, Austria, Switzerland, United States, Canada, Mexico, China, Japan, and South Korea. The company offers iCombi Pro; iCombi Classic; combi ovens; iVario Pro, a multi-functional cooking system; The iHexagon; and ConnectedCooking, a digital kitchen management solution. It also provides accessories, care products, service parts, and services. The company serves restaurants and hotels; catering, such as company canteens, hospitals, schools, universities, military facilities, prisons, and retirement homes; and quick service restaurants, caterers, supermarkets, bakeries, snack outlets, butchers' shops, service stations, and delivery services. It sells its products through independent distribution partners. The company was founded in 1973 and is headquartered in Landsberg am Lech, Germany.…
Industry Peers
Specialty Industrial MachineryKey Statistics
About RATIONAL (ETR: RAA)
›
RATIONAL (ETR: RAA) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Specialty Industrial Machinery industry, part of the Industrials sector, and reports about 2,920 employees.
The shares were at 610.00 EUR on 19 November 2026, down 2.1% over 52 weeks. Its 52-week range is 553.50 EUR to 776.50 EUR: the price is 21.4% below the high and 10.2% above the low.
At a market capitalisation of 6.94B EUR, it trades at 25.4 times trailing earnings and 23.8 times forward earnings. The median trailing P/E of its 20 largest Specialty Industrial Machinery peers is 29.0, a discount of 12% for RAA. It pays a dividend yielding 2.60% (it pays out 67% of its earnings), against a median of 1.69% among the dividend payers in that peer group.
RATIONAL reports return on equity of 27.0%, an operating margin of 26.4% and revenue up 6.5% year over year.
It holds more cash than debt, a net cash position of 511.67M EUR. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 795.86 EUR is 30.5% above the current price. The next earnings report is expected on 18 March 2027.